Sunil Healthcare Limited (BOM:537253)
India · Delayed Price · Currency is INR 75.30
-0.70 (-0.92%)
At close: Sep 10, 2026
Sunil Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 840.63 | 877.19 | 834.21 | 901.92 | 1,105 | 1,192 | |
Revenue Growth | -0.60% | 5.15% | -7.51% | -18.37% | -7.28% | 31.50% |
Cost of Revenue | 304.34 | 341.82 | 366.69 | 463.81 | 501.59 | 522.31 |
Gross Profit | 536.3 | 535.37 | 467.52 | 438.11 | 603.32 | 669.33 |
Selling, General & Admin | 128.57 | 138.53 | 117.96 | 129.39 | 149.15 | 143.89 |
Other Operating Expenses | 283.62 | 249.81 | 246.95 | 267.85 | 289.13 | 315.46 |
Operating Expenses | 474.5 | 472.14 | 428.46 | 458.09 | 511.58 | 554.35 |
Operating Income | 61.79 | 63.24 | 39.06 | -19.98 | 91.74 | 114.99 |
Interest Expense | -62.16 | -48.34 | -56.5 | -47.5 | -33.32 | -25.54 |
Interest & Investment Income | - | 3.02 | 3.28 | 2.55 | 2.11 | 2.16 |
Currency Exchange Gain (Loss) | - | 15.94 | 2.07 | 11.53 | 12.79 | 7.06 |
Other Non Operating Income (Expenses) | 15.52 | -11.05 | -7.22 | -9.24 | -5.55 | -9.29 |
EBT Excluding Unusual Items | 15.15 | 22.8 | -19.31 | -62.65 | 67.77 | 89.38 |
Gain (Loss) on Sale of Investments | - | 0 | - | - | 0.05 | 0.63 |
Gain (Loss) on Sale of Assets | - | 0.04 | - | - | 0.9 | -0.01 |
Other Unusual Items | -1.16 | -0.54 | 7.15 | 8.96 | 26.12 | 2.66 |
Pretax Income | 13.99 | 22.3 | -12.16 | -25.55 | 94.83 | 92.65 |
Income Tax Expense | -21.62 | -17.76 | 2.01 | -7.67 | 28.01 | 28.44 |
Earnings From Continuing Operations | 35.61 | 40.06 | -14.17 | -17.89 | 66.82 | 64.21 |
Net Income | 35.61 | 40.06 | -14.17 | -17.89 | 66.82 | 64.21 |
Net Income to Common | 35.61 | 40.06 | -14.17 | -17.89 | 66.82 | 64.21 |
Net Income Growth | 1851.40% | - | - | - | 4.07% | - |
Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 10 | 10 |
Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 10 | 10 |
Shares Change | 0.32% | - | - | - | - | - |
EPS (Basic) | 3.47 | 3.91 | -1.38 | -1.74 | 6.52 | 6.26 |
EPS (Diluted) | 3.47 | 3.91 | -1.38 | -1.74 | 6.52 | 6.26 |
EPS Growth | 1845.22% | - | - | - | 4.07% | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 185.61 | 20.89 | -258.62 | 32.67 | 134.73 |
Free Cash Flow Per Share | - | 18.10 | 2.04 | -25.22 | 3.19 | 13.14 |
Gross Margin | 63.80% | 61.03% | 56.04% | 48.58% | 54.60% | 56.17% |
Operating Margin | 7.35% | 7.21% | 4.68% | -2.21% | 8.30% | 9.65% |
Profit Margin | 4.24% | 4.57% | -1.70% | -1.98% | 6.05% | 5.39% |
Free Cash Flow Margin | - | 21.16% | 2.50% | -28.67% | 2.96% | 11.31% |
EBITDA | 126.4 | 127.57 | 102.44 | 36.72 | 155.1 | 175.38 |
EBITDA Margin | 15.04% | 14.54% | 12.28% | 4.07% | 14.04% | 14.72% |
D&A For EBITDA | 64.6 | 64.33 | 63.37 | 56.7 | 63.36 | 60.39 |
EBIT | 61.79 | 63.24 | 39.06 | -19.98 | 91.74 | 114.99 |
EBIT Margin | 7.35% | 7.21% | 4.68% | -2.21% | 8.30% | 9.65% |
Effective Tax Rate | - | - | - | - | 29.54% | 30.70% |
Revenue as Reported | 856.15 | 899.02 | 847.6 | 954.12 | 1,150 | 1,208 |